Company profile: ME Therapeutics
1.1 - Company Overview
Company description
- Provider of biotechnology drug discovery and development focused on myeloid cell-targeted immuno-oncology therapies.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to ME Therapeutics
Umoja Biopharma
HQ: United States
Website
- Description: Provider of next-generation immunotherapies intended to combat cancer.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Umoja Biopharma company profile →
Immago
HQ: United Kingdom
Website
- Description: Provider of antibody-modulating enzyme approaches to enhance antibody-based cancer therapies, applying 'receptor refocusing' to modulate the endogenous antibody repertoire and enhance immune-mediated killing of cancer cells.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Immago company profile →
Ambit Biosciences
HQ: United States
Website
- Description: Provider of small molecule kinase inhibitor discovery and development for cancer, autoimmune, and inflammatory diseases, including quizartinib (AC220), a potent, selective FLT3 inhibitor for AML, AC410 (JAK2 inhibitor), and AC708 (CSF1R inhibitor), supported by the KinomeScan platform for screening kinase inhibitors.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ambit Biosciences company profile →
Applied Proteomics
HQ: United States
Website
- Description: Provider of protein biomarker discovery solutions, including SimpliPro Colon Test—a blood test for healthcare providers to aid colorectal health assessment by measuring 11 protein markers associated with colorectal cancer and advanced adenoma—plus a mass-spectrometry (tandem LCMS) proteomics platform, proprietary workflow management system, and advanced visualization tools.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Applied Proteomics company profile →
Tempest Therapeutics
HQ: United States
Website
- Description: Provider of small molecule therapeutics that modulate anti-tumor pathways, including TPST-1120, an oral PPARα antagonist designed to inhibit fatty acid oxidation and inflammation with potential in hepatocellular, renal cell, and cholangiocarcinoma, and TPST-1495, an oral dual EP2/EP4 antagonist in Phase 1/1b combination studies to reduce tumor growth and immune suppression.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tempest Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for ME Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to ME Therapeutics
2.2 - Growth funds investing in similar companies to ME Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for ME Therapeutics
4.2 - Public trading comparable groups for ME Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →